Cardiovascular considerations in coronavirus disease 2019 with a special focus on arrhythmia

Tiffany Y. Hu, Justin Z. Lee, Samuel J. Asirvatham

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus responsible for the coronavirus disease 2019 (COVID-19) pandemic, has significant cardiovascular manifestations. Several studies to date have suggested worse outcomes occur in patients with elevated troponin levels. Among hospitalized patients in Wuhan, China, arrhythmias including malignant ventricular arrhythmia have been reported. Conduction abnormalities in COVID-19 patients have also been described. Additionally, there have been concerns raised regarding COVID-19–related myocarditis, of which reported biopsy-proven cases to date appear to be rare. In this review, we address COVID-19 concerns for the cardiologist and electrophysiologist, including arrhythmia and conduction abnormalities, myocarditis, and arrhythmia in critically ill patients; angiotensin-converting enzyme 2 in cardiac patients; hypercoagulability; and the drug properties of hydroxychloroquine as one of the potential therapies under review.

Original languageEnglish (US)
JournalJournal of Innovations in Cardiac Rhythm Management
Issue number7
StatePublished - Jul 2020


  • Arrhythmia
  • COVID-19
  • Cardiovascular
  • Myocarditis
  • SARS-cov-2

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)


Dive into the research topics of 'Cardiovascular considerations in coronavirus disease 2019 with a special focus on arrhythmia'. Together they form a unique fingerprint.

Cite this